The extent to which decrease in PAI-1 may improve endothelial function in PCOS patients is still unclear and may be mediated by diminishing its prothrombotic, antithrombotic, and vascular smooth muscle proliferation effects. This evidence concerns the gene SERPINE1 and polycystic ovary syndrome.